Immune activating peptide agonists are promising antitumor agents for cancer patients who are unresponsive to immunotherapy. Together with non-invasive imaging, peptide agonists are a powerful strategy for targeted treatment and therapeutic efficacy monitoring. In this webinar, David Piwnica-Worms will talk about the potential of agonist peptides to overcome immunotherapy resistance through their ability to elicit lasting antitumor responses.
Topics to be covered
- Using agonist peptides to improve cancer immunotherapy
- Non-invasive molecular imaging strategies to interrogate signal transduction and cell trafficking
Wednesday, March 29th, 2023 | 2:30 PM - 3:30 PM Eastern Time
This webinar will be available to view live and on demand.
David Piwnica-Worms, MD, PhD
The University of Texas MD Anderson Cancer Center